ABG-WTT Global Life Science Capital Partners GP Ltd — 13F Holdings & Portfolio
CIK 1832108 · latest 13F-HR filed 2026-08-14
ABG-WTT Global Life Science Capital Partners GP Ltd manages $8.6M in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are CBLL (62.61%), RPID (37.39%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 0, and trimmed 2.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
CHEUNG KONG CNTR II, 10 HARCOURT ROAD
CENTRAL, HONG KONG, K3 000000
$8.6M
Long-equity book
2
Distinct positions
2026-06-30
Filed 2026-08-14
+0 / −0 / ↑0 / ↓2
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $8.6M | 2 | 0001193125-26-352439 |
| 2026-03-31 | 2026-05-18 | $12.3M | 2 | 0001193125-26-227557 |
| 2025-12-31 | 2026-02-17 | $15.0M | 2 | 0001193125-26-055042 |
| 2025-09-30 | 2025-11-14 | $18.7M | 2 | 0001193125-25-283037 |